36 min listen
NEUVC #281: Ondrej Bartos, GP at Credo Ventures on having patience while building a career in VC
FromEUVC
NEUVC #281: Ondrej Bartos, GP at Credo Ventures on having patience while building a career in VC
FromEUVC
ratings:
Length:
44 minutes
Released:
Feb 17, 2024
Format:
Podcast episode
Description
Join us for a new episode of the NEUVC series dedicated to those embarking on their journey in the VC. In this episode, Freddie Macpherson, Associate at Isomer Capital, and Linda Võeras, Investment Manager at Karma Ventures, are joined by Ondrej Bartos, General Partner at Credo Ventures.Ondrej is the Founding GP at Credo Ventures, a 75m€ Seed stage venture fund in Prague (and a bit elsewhere!) to back Central Eastern European Tech Startups.Credo is investing out of Fund IV with a total €250M AUM and an established portfolio of 60 companies and notable investments, including UI Path, ProductBoard, PriceFX, Resistant AI, and Eleven Labs.Go to eu.vc for our core learnings and the full video interview ?Chapters:00:02:00 - Focus on Early Stage Investments00:04:10 - Spotting Patterns in Venture Capital00:06:17 - The Beginning of Venture Investing in the Region00:08:39 - The Growth of Tech Talent in the Region00:11:00 - The Growth and Progress of the CE Region00:12:59 - Building Relationships through Networking00:15:08 - Finding Great Deals in the Startup World00:17:25 - Learning from Investments and Founders00:19:49 - Evaluating the Right Investment00:21:50 - The Risk of Investing in Startups00:24:13 - The Role of Luck in Success00:28:26 - The Importance of Founder in Startup Investment00:30:45 - The Importance of Respect and Honesty in Relationships00:35:16 - Listening and adding value in boardrooms00:37:38 - The Role of a Board Member00:39:53 - Skills for Success in Venture Capital00:41:53 - The Importance of People in Venture Capital
Released:
Feb 17, 2024
Format:
Podcast episode
Titles in the series (100)
#1 Marc Lohrmann, Vesalius Biocapital: Episode 1 features Marc Lohrmann, Managing Partner of Vesalius Biocapital III, a 120 €M venture capital fund investing in late-stage companies in drug development, medical devices & diagnostics and eHealth / mHealth, across all of Europe. Prior to... by EUVC